Your session is about to expire
← Back to Search
Procedure
Fractional Radiofrequency vs Fractional Photothermolysis for Acne Scars
N/A
Waitlist Available
Led By Murad Alam, MD
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 hour at baseline and week 16
Awards & highlights
Study Summary
This trial will compare two treatments for improving the appearance of acne scars.
Who is the study for?
This trial is for adults with specific types of acne scars on their face who are in good health and can give informed consent. It's not for those allergic to local anesthetics like lidocaine, have eyelid disfigurements, recent facial treatments (injectables or resurfacing), pregnant or breastfeeding individuals, recent isotretinoin users, or a history of abnormal scarring.Check my eligibility
What is being tested?
The study compares two acne scar treatments: ePrime fractional radiofrequency and Fraxel (1550-nm fractional photothermolysis). Participants will receive one treatment on each side of their face to see which improves the appearance of acne scars better.See study design
What are the potential side effects?
Potential side effects may include skin redness, swelling, pain at the treatment site, temporary changes in skin coloration, blistering and bruising. Rarely there could be scarring from the treatment itself.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 hour at baseline and week 16
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 hour at baseline and week 16
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in best overall cosmetic appearance (right side or left side better)rated by a blinded dermatologist from baseline to week 16
Trial Design
2Treatment groups
Active Control
Group I: 1550-nm Fractional PhotothermolysisActive Control1 Intervention
Subjects will be randomly assigned to receive fractional radiofrequency treatment to either the right or left side of the face and the contralateral side will receive 1550-nm fractional photothermolysis. Subjects will receive treatments at baseline, week 4, and week 8 for a total of three treatments. Follow up visits will take place at week 16, two months following the last treatment visit.
Group II: Fractional RadiofrequencyActive Control1 Intervention
Subjects will be randomly assigned to receive fractional radiofrequency treatment to either the right or left side of the face and the contralateral side will receive 1550-nm fractional photothermolysis. Subjects will receive treatments at baseline, week 4, and week 8 for a total of three treatments. Follow up visits will take place at week 16, two months following the last treatment visit.
Find a Location
Who is running the clinical trial?
Northwestern UniversityLead Sponsor
1,585 Previous Clinical Trials
917,215 Total Patients Enrolled
Murad Alam, MDPrincipal InvestigatorNorthwestern University
69 Previous Clinical Trials
2,564 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are allergic to lidocaine or prilocaine.You have an eyelid abnormality such as ectropion or a disfigurement.You have acne scars on your face that are at least 2x2 cm in size and have a specific shape, either "ice pick" or "boxcar".You have had facial injections or resurfacing procedures within the past 6 months.You have had botox or laser treatment on your face within the last 3 months.You have an infection, open wound on your face, or a severe skin condition that would affect the treatment of your acne scars using energy devices.You have a history of forming abnormal scars, such as keloids, in the area where the treatment will be done.
Research Study Groups:
This trial has the following groups:- Group 1: 1550-nm Fractional Photothermolysis
- Group 2: Fractional Radiofrequency
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger